细胞周期蛋白依赖激酶抑制剂化学品
CAS 登录号 | 产品名称 | 分子式 |
---|
1073485-20-7 | 3-[[6-(2-甲氧基苯基)-4-嘧啶基]氨基]苯甲磺酰胺 | C18H18N4O3S |
1169562-71-3 | 8-氯-2-(2S)-2-吡咯烷基苯并呋喃并[3,2-d]嘧啶-4(3H)-酮盐酸盐 | C14H12ClN3O2.x(HCl) |
1211441-98-3 | LEE 011 | C23H30N8O |
1231930-82-7 | N-[5-[(4-乙基-1-哌嗪基)甲基]-2-吡啶基]-5-氟-4-[4-氟-2-甲基-1-异丙基-1H-苯并咪唑-6-基]-2-嘧啶胺甲烷磺酸盐 | C27H32F2N8.CH4O3S |
1285702-20-6 | 5-[4-[[(5-甲基-2-呋喃基)甲基]氨基]-6-喹唑啉基]-2-呋喃甲醇 | C19H17N3O3 |
131740-09-5 | 夫拉平度盐酸盐; (-)-2-(2-氯苯基)-5,7-二羟基-8-[(3S,4R)-3-羟基-1-甲基-4-哌啶基]-4H-1-苯并吡喃-4-酮盐酸盐 | C21H20ClNO5.HCl |
1397219-81-6 | BS 181 盐酸盐 | C22H32N6.HCl |
186692-46-6 | Roscovitine; 6-(苄基氨基)-2(R)-[[1-(羟甲基)丙基]氨基]-9-异丙基嘌呤 | C19H26N6O |
212844-53-6 | Purvalanol A | C19H25ClN6O |
220036-08-8 | NU6027 | C11H17N5O2 |
300801-52-9 | 1-(3-乙基-5-甲氧基-2(3H)-苯并噻唑亚基)-2-丙酮 | C13H15NO2S |
345627-80-7 | BMS-3870032; N-[5-[(5-叔丁基-1,3-恶唑-2-基)甲硫基]-1,3-噻唑-2-基]哌啶-4-甲酰胺 | C17H24N4O2S2 |
377090-84-1 | SU 9516 | C13H11N3O2 |
443797-96-4 | 4-[[5-氨基-1-(2,6-二氟苯甲酰基)-1H-1,2,4-三唑-3-基]氨基]苯磺酰胺 | C15H12F2N6O3S |
582315-72-8 | (4-丁氧基-1H-吡唑并[3,4-b]吡啶-5-基)(2,6-二氟-4-甲基苯基)-甲酮 | C18H17F2N3O2 |
602306-29-6 | AZD 5438; 4-[2-甲基-1-异丙基-1H-咪唑-5-基]-N-[4-(甲磺酰基)苯基]-2-嘧啶胺 | C18H21N5O2S |
718630-59-2 | PHA-793887; 3-甲基-N-[1,4,5,6-四氢-6,6-二甲基-5-[(1-甲基-4-哌啶基)甲酰基]吡咯并[3,4-c]吡唑-3-基]丁酰胺 | C19H31N5O2 |
741713-40-6 | Ro 4584820; [4-氨基-2-[(1-甲磺酰基哌啶-4-基)氨基]嘧啶-5-基](2,3-二氟-6-甲氧基苯基)甲酮 | C18H21F2N5O4S |
802539-81-7 | PHA 848125; 4,5-二氢-N,1,4,4-四甲基-8-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-1H-吡唑并[4,3-h]喹唑啉-3-甲酰胺 | C25H32N8O |
827022-33-3 | Palbociclib isethionate | C24H29N7O2.C2H6O4S |
844442-38-2 | AT 7519; N-(4-哌啶基)-4-(2,6-二氯苯甲酰氨基)-1H-吡唑-3-甲酰胺 | C16H17Cl2N5O2 |
845714-00-3 | CAY 10572; 1,5,6,7-四氢-2-(4-吡啶基)-4H-吡咯并[3,2-c]吡啶-4-酮 | C12H11N3O |
872573-93-8 | Ro 3306; 2-[[(噻吩-2-基)甲基]氨基]-5-[1-(喹啉-6-基)甲-(Z)-亚基]噻唑-4-酮 | C18H13N3OS2 |
920113-03-7 | P276-00 | C21H21Cl2NO5 |